APS

29th APS Annual Convention · 2017

Creatine As Treatment for Depression and Anxiety in Depressed, Methamphetamine-Using Women

Boston, MA · May 2017

Poster Session · Clinical Science

  • Lindsay Scholl
    University of Utah
  • Young-Hoon Sung
    University of Utah
  • Xianfeng Shi
    University of Utah
  • Tracy Hellem
    Montana State University
  • Perry Renshaw
    University of Utah

Abstract

Methamphetamine use, which commonly leads to depression and anxiety, is especially prevalent in women. Since typical SSRI treatment for depressed meth users has been shown to worsen meth use, this study examines creatine as a novel treatment for depression and anxiety in female meth users.

Substance Abuse

← Poster Session XIII